Results 131 to 140 of about 9,605 (202)

Biologics and biosimilars medication errors in Saudi Arabia: a nationwide retrospective observational real-world study. [PDF]

Front Med (Lausanne)
Alshammri NT, Alluwaymi WS, Assiri GA, Alshammari TM.   +3 more
europepmc   +1 more source

Tuberculosis prophylaxis and long-term safety in adalimumab biosimilar therapy: The need for strengthened vigilance. [PDF]

Indian J Med Res
C S C, Nevil S, Charles SA.
europepmc   +1 more source

Biosimilars in Adult and Pediatric Noninfectious Uveitis. [PDF]

Clin Ophthalmol
Ploeger CG, Carvalho Soares Valentim C, Guner ME, Kabaalioglu Guner M.   +3 more
europepmc   +1 more source

Efficacy of immunotherapy and targeted therapy for unresectable hepatocellular carcinoma: analysis of survival curves. [PDF]

Front Med (Lausanne)
Zhou W, Xu P.
europepmc   +1 more source

Short-term efficacy and safety of infliximab biosimilar (HS626) in inducing remission of inflammatory bowel disease: A real-world single-center study. [PDF]

Medicine (Baltimore)
Huang YS, Lai DP, Nong H, Zhang T, Chen ZY, Zeng WB, Huang XP, Lin YY.   +7 more
europepmc   +1 more source

Biosimilars in pemphigus vulgaris

Indian Journal of Dermatology, 2014
Sharmila Patil, Nidhi Sharma, Kiran Godse, Nitin Nadkarni   +3 more
openaire   +3 more sources

Non-signaling protein therapeutics: a mechanism-based regulatory framework to modernize biosimilar development and global harmonization. [PDF]

Front Med (Lausanne)
Niazi SK.
europepmc   +1 more source

Regulatory Definitions and Classification of Biosimilar Medications Across the 6 Regions of the World Health Organization: A Scoping Review.

JAMA Health Forum
Watanabe JH, Strand MW, Walvekar M, Alfonso-Cristancho R.   +3 more
europepmc   +1 more source

AVT04, a Biosimilar to Reference Product Ustekinumab, for the Treatment of Plaque Psoriasis: Insights from a Real-World Experience up to 28 Weeks. [PDF]

Dermatol Ther (Heidelb)
Mortato E, Talamonti M, Savastano L, Marcelli L, Tofani L, Gneo V, Marrapodi D, Ingrosso MR, Bianchi L, Galluzzo M.   +9 more
europepmc   +1 more source

Effect of Mirikizumab on Clinical and Endoscopic Outcomes Based on Prior Advanced Therapy Failure in Patients With Moderately to Severely Active Ulcerative Colitis. [PDF]

United European Gastroenterol J
Hart A, Navabi S, D'Haens G, Matsuoka K, Martín-Arranz MD, Atreya R, Samaan KH, Dhesi E, Redondo I, Zhu B, Paulissen J, Zaremba-Pechmann L, Baygani S, Limdi J, Laharie D, Danese S.   +15 more
europepmc   +1 more source